There is conflicting evidence regarding bisphosphonates and atrial fibrillation (AF) risk in osteoporosis patients. However, bisphosphonates are used in much higher doses in treatment of bone ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback